20 Participants Needed

Bowel Gas Detection Device for Laparoscopic Colectomy Procedures

KT
KT
KH
JS
JB
RR
AS
Overseen ByAnanya Sen
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Weill Medical College of Cornell University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Undetected bowel perforation is a rare but dangerous complication of laparoscopic surgery. If the injury is not detected and treated at the time of the surgical procedure, the patient can suffer severe complications, including septic shock and eventually death. The investigator's goal is to test a novel device that can detect bowel gas leakage from perforation and alert the surgeon during the operation by evaluating the gases present in the insufflated abdomen during surgery. This study will determine the ability of the device to be attached to a standard trocar during the operation and periodically draw small samples or aliquots of gas from the abdomen to evaluate the gas and accurately detect gaseous content from the bowel. Before the device can be used to detect bowel perforations, the investigators must first ensure that it can accurately detect bowel gas in an insufflated abdomen.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the Bowel Gas Detection Device, Perf-AlertTM, for laparoscopic colectomy procedures?

The research suggests that analyzing gas in the colon using imaging techniques is a reliable way to assess bowel function after surgery, which may support the use of the Bowel Gas Detection Device in similar contexts.12345

How does the Bowel Gas Detection Device treatment differ from other treatments for bowel conditions?

The Bowel Gas Detection Device is unique because it focuses on detecting and analyzing bowel gas during laparoscopic colectomy procedures, which can help assess and manage functional bowel disorders. Unlike other treatments that may focus on symptoms or surgical interventions, this device provides real-time information about gas distribution, potentially improving surgical outcomes and postoperative recovery.13567

Research Team

AP

Alessio Pigazzi, MD,PhD

Principal Investigator

Weill Medical College of Cornell University

Eligibility Criteria

This trial is for adults over 18 who need elective laparoscopic right colectomy with intracorporeal anastomosis and can give informed consent. It's not for non-English speakers, emergency cases, peritoneal dialysis patients, those with abdominal infections or fistulas, or pregnant/breastfeeding individuals.

Inclusion Criteria

Subject signed inform consent
I am scheduled for a specific surgery on the right side of my colon.

Exclusion Criteria

I am currently undergoing peritoneal dialysis.
I am having emergency surgery for a ruptured right colon or injury.
I am under 18 years old.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgical Procedure

Participants undergo laparoscopic right colectomy with intracorporeal anastomosis while the novel device is tested for detecting bowel gas leakage.

During surgery
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the surgical procedure.

4 weeks

Treatment Details

Interventions

  • Bowel Gas Detection Device
Trial Overview The study tests a new device designed to detect bowel gas from perforations during laparoscopic surgery by sampling gases in the abdomen. The goal is to ensure it accurately identifies bowel gas without interrupting the procedure.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Cohort 2: Continuous monitoringExperimental Treatment1 Intervention
Cohort 2: Continuous monitoring: 10 subjects with continuous monitoring of bowel gases through the surgery. The level of H2 and CH4 gases will be noted at the 8 predetermined time points during the continuous monitoring as well.
Group II: Cohort 1: Predetermined points measurementExperimental Treatment1 Intervention
Cohort 1: Predetermined points measurement: 10 subjects with measurement of bowel gas at 8 predetermined time points during right laparoscopic colectomy as follow: 1. Initiation of surgery/laparoscopy start Insufflation 2. Abdominal exploration 3. Completion of colon mobilization 4. Colon transection 5. At Colotomy 6. At Enterotomy 7. Anastomosis completion 8. End of surgery- after re-insufflation before closure

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

Sentire Medical Systems

Collaborator

Trials
1
Recruited
20+

Findings from Research

In a study of 40 rectosigmoid cancer patients post-surgery, colon gas volume analysis was found to be a useful method for evaluating colonic transit time, with specific transit times recorded for the right and left colon.
The study revealed a significant correlation between the ratio of left colon transit time to right colon transit time and the ratio of left colon gas volume to right colon gas volume, suggesting that gas volume analysis can provide insights into bowel function after surgery.
Relevance of abdominal gas analysis and transit study after colorectal cancer surgery.Seike, K., Koda, K., Oda, K., et al.[2019]
A novel real-time bowel sound monitoring system was evaluated in 14 patients undergoing gastric surgery, showing a significant increase in bowel sounds postoperatively (2.5 counts per minute) compared to preoperative levels (1.4 counts per minute).
The study found a significant negative correlation between postoperative bowel sound count and operation time, suggesting that shorter surgical durations may enhance recovery of bowel function, supporting the benefits of minimally invasive surgical techniques.
Real-time bowel sound analysis using newly developed device in patients undergoing gastric surgery for gastric tumor.Namikawa, T., Yamaguchi, S., Fujisawa, K., et al.[2022]
A new stool analysis method using headspace gas chromatography and a metal oxide sensor can differentiate between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) with a sensitivity of 76% and specificity of 88%.
This non-invasive testing approach shows promise for accurately diagnosing these two distinct gastrointestinal diseases, achieving an overall predictive accuracy of 76% based on patient samples.
The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients.Shepherd, SF., McGuire, ND., de Lacy Costello, BP., et al.[2023]

References

Relevance of abdominal gas analysis and transit study after colorectal cancer surgery. [2019]
Real-time bowel sound analysis using newly developed device in patients undergoing gastric surgery for gastric tumor. [2022]
The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients. [2023]
Validation of an acoustic gastrointestinal surveillance biosensor for postoperative ileus. [2021]
Gas volume analysis and postoperative bowel functional disorders in patients who received anterior resection for rectal cancer. [2019]
Recording and Analysis of Bowel Sounds. [2022]
Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. [2016]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security